Aurbindo Pharma announced that it received two approvals from Swissmedic for the licence of Amlodipine APL 5mg and 10mg Tablets and Melformin APL500mg, 850mg and 1000mg tablets. Aurbindo now has four Products approvals from Swissmedic. Amlodipine used in Cardio Vascular disorder and Melformin is used for the treatment of diabetes mellitus. Its stock traded at Rs 705.85 up by 1.46% from previous close of Rs 695.70 on BSE.
Related Pages :
